| 产品详情 |
| Edit |   |
| Product Name | Recombinant Human VEGF R3/Flt-4 Fc Chimera Protein, CF |
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 145-150 kDa, 90-95 kDa and 75-80 kDa, reducing conditions. MW (theoretical): 112 kDa (monomer). The Recombinant Human VEGF R3/Flt-4 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human VEGF R3/Flt-4 Fc Chimera Protein has been validated for the following applications: Binding Activity. |
| Size | 50 ug |
| Concentration | n/a |
| Applications | Binding Activity |
| Other Names | EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGFR3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4 |
| Gene, Accession, CAS # | FLT4, Gene ID: 2324, Accession: P35916 |
| Catalog # | 349-F4-050 |
| Price | |
| Order / More Info | Recombinant Human VEGF R3/Flt-4 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
| Product Specific References | PubMed: 12594815, 16061674, 16462734, 16998586, 17535974, 18425119, 19157860, 19825968, 22959908, 23404505, 27327585, 27822137, 27852824, 29180757, 30769285 |
| 产品资料 |
|
|